EUDA HEALTH HOLDINGS LTD
EUDANASDAQTrading Snapshot
- Day Range
- $15.76 β $16.11
- 52-Week Range
- $5.26 β $86.00
- Volume
- $2.93B
- Avg Volume
- $2.43B
- Shares Outstanding
- 1.9M
- Next Earnings
- Nov 27, 2026
Fundamentals Snapshot
- Annual Revenue
- $7M
- Last Q Revenue
- $7M
- P/E Ratio
- -6.4
- P/S Ratio
- 2.6x
- EPS (TTM)
- $-2.56
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +1.7%
Why Investors Own EUDA
- βHigh-growth profile β revenue up +54.9% YoY with expanding US Equity exposure.
- βHealthy economics β 33% gross margin and 22% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
EUDA HEALTH HOLDINGS LTD
EUDAAbout EUDA HEALTH HOLDINGS LTD
EUDA Health Limited, established in 2019, is a Singapore-based enterprise dedicated to advancing digital healthcare. It provides an innovative platform facilitating online medical consultations for routine, non-urgent health concerns. This entity functions as a subsidiary of Watermark Developments Limited.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Price Target
βLatest News & Updates

EUDA Health Subsidiary Melana International Wins SME100 Awards 2026 Singapore
SINGAPORE, AUGUST, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Β EUDA Health Holdings Limited (NASDAQ: EUDA) (βEUDAβ or the βCompanyβ), a Singapore-based distributor of third-party wellness and non-invasive healthcare products and

EUDA Health Announces Collaboration to Advance an Integrated iPSC Cell Therapy Program for Oncology and Wellness β’ Targets global distribution for innovative Oncology products
SINGAPORE, July 30, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) a Singapore-based distributor of third-party provided wellness and non-invasive healthcare products and services in Asia, with a fo

EUDA Health Announces Collaboration to Advance an Integrated iPSC Cell Therapy Program for Oncology and Wellness β’ Targets global distribution for innovative Oncology products
SINGAPORE, July 30, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) a Singapore-based distributor of third-party provided wellness and non-invasive healthcare products and services in Asia, with a fo

EUDA Health Signs Important Tri-Party Memorandum of Understanding with GO POSB Organoids and Shenzhen Inno to Significantly Advance Next-Generation iPSC and NK-TCR Cell Therapies
SINGAPORE, July 28, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) a Singapore-based distributor of third-party provided wellness and non-invasive healthcare products and services in Asia, with a fo

Phreesia (NYSE:PHR) & EUDA Health (NASDAQ:EUDA) Head-To-Head Review
EUDA Health (NASDAQ: EUDA - Get Free Report) and Phreesia (NYSE: PHR - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength